Brian Young - Novanta Chief Human Resource Officer
| NOVT Stock | USD 157.81 1.57 0.99% |
Executive
Mr. Brian Young serves as Chief Human Resource Officer of the company. Mr. Young brings more than 20 years of human resources leadership experience in both public and private companies serving Original Equipment Manufacturers of Class I, II III medical devices, industrial control technology and advanced materials. From July 2014 to March 2015, Mr. Young served as Global Human Resource Leader for Hollingsworth Vose Company. From September 2011 to November 2013, Mr. Young served as Vice President Human Resource Officer for CIRCOR International, Inc. From September 2010 to August 2011, Mr. Young served as Director Total Rewards for CIRCOR. In addition, from June 2003 to August 2010, Mr. Young served in various leadership roles with Lake Region Medical . Mr. Youngs early career experience was in General Human Resource Management with a specialization in training and development since 2016.
| Age | 55 |
| Tenure | 8 years |
| Address | 125 Middlesex Turnpike, Bedford, MA, United States, 01730 |
| Phone | 781 266 5700 |
| Web | https://www.novanta.com |
Brian Young Latest Insider Activity
Tracking and analyzing the buying and selling activities of Brian Young against Novanta stock is an integral part of due diligence when investing in Novanta. Brian Young insider activity provides valuable insight into whether Novanta is net buyers or sellers over its current business cycle. Note, Novanta insiders must abide by specific rules, including filing SEC forms every time they buy or sell Novanta'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Brian Young over two months ago Novanta exotic insider transaction detected | ||
Brian Young over two months ago Payment of 156 shares by Brian Young of Novanta subject to Rule 16b-3 | ||
Brian Young over two months ago Disposition of 351 shares by Brian Young of Novanta subject to Rule 16b-3 | ||
Brian Young over six months ago Exercise or conversion by Brian Young of 2575 shares of Novanta subject to Rule 16b-3 |
Novanta Management Efficiency
The company has return on total asset (ROA) of 0.0596 % which means that it generated a profit of $0.0596 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1165 %, meaning that it created $0.1165 on every $100 dollars invested by stockholders. Novanta's management efficiency ratios could be used to measure how well Novanta manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to 0.13 in 2024. Return On Capital Employed is likely to gain to 0.12 in 2024. At this time, Novanta's Liabilities And Stockholders Equity is comparatively stable compared to the past year. Non Current Liabilities Total is likely to gain to about 434.1 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 106.1 M in 2024.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Inbal Dangur | Vishay Precision Group | N/A | |
| Kok Wong | Sensata Technologies Holding | N/A | |
| Milwaukee | Badger Meter | N/A | |
| Marina Donovan | Itron Inc | N/A | |
| Ganesh Kalpundi | Vontier Corp | N/A | |
| Jing Chang | Sensata Technologies Holding | N/A | |
| Alison Mallahan | Itron Inc | N/A | |
| Roland Desilets | Vishay Precision Group | 55 | |
| Charmaine Riggins | Vontier Corp | 51 | |
| Michael Callahan | Vishay Precision Group | N/A | |
| Rafi Uzan | Vishay Precision Group | 58 | |
| Justin Patrick | Itron Inc | 51 | |
| David Stott | Sensata Technologies Holding | N/A | |
| John Marcolini | Itron Inc | 51 | |
| Rob Stefanic | Sensata Technologies Holding | N/A | |
| Paul Vincent | Itron Inc | N/A | |
| Dan Saniti | Electro Sensors | N/A | |
| Milwaukee WI | Badger Meter | N/A | |
| Ryan Edelman | Vontier Corp | N/A | |
| Mike Alfred | ESCO Technologies | N/A | |
| Rafi Ouzan | Vishay Precision Group | 58 | |
Management Performance
| Return On Equity | 0.12 | ||||
| Return On Asset | 0.0596 |
Novanta Leadership Team
Elected by the shareholders, the Novanta's board of directors comprises two types of representatives: Novanta inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Novanta. The board's role is to monitor Novanta's management team and ensure that shareholders' interests are well served. Novanta's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Novanta's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Stephen Bershad, Independent Chairman of the Board | ||
| Ray Nash, Corp Leader | ||
| Michele Welsh, General Secretary | ||
| Sarah Betadam, Chief Officer | ||
| Dominic Romeo, Independent Director | ||
| Heinrich Dreyer, Group Solutions | ||
| Ira Lamel, Independent Director | ||
| Lonny Carpenter, Independent Director | ||
| Brian King, Independent Director | ||
| Peter Chang, Corporate Officer | ||
| Brian Young, Chief Human Resource Officer | ||
| Charlie Webster, Executive Chain | ||
| Thomas Secor, Independent Director | ||
| Matthijs Glastra, CEO Chairman | ||
| Dennis Fortino, Independent Director | ||
| John Roush, CEO, Director | ||
| Anna Fain, Equity Diversity | ||
| Harry Bosco, Independent Director | ||
| Chuck Ravetto, Group Group | ||
| Robert Buckley, Chief Officer |
Novanta Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Novanta a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.12 | ||||
| Return On Asset | 0.0596 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.1 % | ||||
| Current Valuation | 6.01 B | ||||
| Shares Outstanding | 35.89 M | ||||
| Shares Owned By Insiders | 0.80 % | ||||
| Shares Owned By Institutions | 99.20 % | ||||
| Number Of Shares Shorted | 1.72 M | ||||
| Price To Earning | 126.20 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novanta. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For more information on how to buy Novanta Stock please use our How to Invest in Novanta guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Complementary Tools for Novanta Stock analysis
When running Novanta's price analysis, check to measure Novanta's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novanta is operating at the current time. Most of Novanta's value examination focuses on studying past and present price action to predict the probability of Novanta's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novanta's price. Additionally, you may evaluate how the addition of Novanta to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Novanta's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novanta. If investors know Novanta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novanta listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.19) | Earnings Share 2.02 | Revenue Per Share 24.597 | Quarterly Revenue Growth (0.03) | Return On Assets 0.0596 |
The market value of Novanta is measured differently than its book value, which is the value of Novanta that is recorded on the company's balance sheet. Investors also form their own opinion of Novanta's value that differs from its market value or its book value, called intrinsic value, which is Novanta's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novanta's market value can be influenced by many factors that don't directly affect Novanta's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Novanta's value and its price as these two are different measures arrived at by different means. Investors typically determine if Novanta is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novanta's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.